Skip to main content
PMC home page
Gut logoLink to Gut
. 1994 Apr;35(4):511–516. doi: 10.1136/gut.35.4.511

Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease.

K R Gardiner 1, A D Crockard 1, M I Halliday 1, B J Rowlands 1
PMCID: PMC1374801  PMID: 8174990

Abstract

Macrophage major histocompatibility complex (MHC) class II antigen expression is associated with defective antigen presentation to T lymphocytes in animals and is predictive of patient outcome after major trauma or sepsis. In this study, class II antigen (HLA-DR and DQ) expression on peripheral blood monocytes was investigated in patients with inflammatory bowel disease in relation to disease activity and outcome. The percentage positivity and fluorescent intensity of expression of HLA-DR and DQ antigens on monocytes were determined in whole blood samples using dual colour immunofluorescence labelling and flow cytometry. Disease activity was assessed using clinical and laboratory indices. There was no significant difference in percentage positivity or fluorescent intensity of class II antigen expression between patients with Crohn's disease, those with ulcerative colitis, and healthy volunteers. The percentage of monocytes displaying HLA-DR positivity was significantly decreased in patients with active ulcerative colitis (active %: 49.5 (5.6); inactive %: 78.9 (6.9); p = 0.01). Data expressed as mean (SEM). In patients requiring surgical resection of diseased bowel, the percentage of monocytes displaying HLA-DR positivity (51.9 (4.0) %) was significantly reduced compared with patients receiving medical treatment alone (81.1 (3.5) %; p < 0.001). Reduced monocyte HLA-DR expression is therefore associated with disease activity and seems to predict outcome in patients with inflammatory bowel disease.

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appel S. H., Wellhausen S. R., Montgomery R., DeWeese R. C., Polk H. C., Jr Experimental and clinical significance of endotoxin-dependent HLA-DR expression on monocytes. J Surg Res. 1989 Jul;47(1):39–44. doi: 10.1016/0022-4804(89)90045-0. [DOI] [PubMed] [Google Scholar]
  2. Auffray C., Kuo J., DeMars R., Strominger J. L. A minimum of four human class II alpha-chain genes are encoded in the HLA region of chromosome 6. Nature. 1983 Jul 14;304(5922):174–177. doi: 10.1038/304174a0. [DOI] [PubMed] [Google Scholar]
  3. Ayala A., Perrin M. M., Chaudry I. H. Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens. Immunology. 1990 May;70(1):33–39. [PMC free article] [PubMed] [Google Scholar]
  4. Benacerraf B. Role of MHC gene products in immune regulation. Science. 1981 Jun 12;212(4500):1229–1238. doi: 10.1126/science.6165083. [DOI] [PubMed] [Google Scholar]
  5. Bull D. M., Ignaczak T. F. Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease. Gastroenterology. 1973 Jan;64(1):43–50. [PubMed] [Google Scholar]
  6. Böyum A. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Invest Suppl. 1968;97:51–76. [PubMed] [Google Scholar]
  7. Cheadle W. G., Hershman M. J., Wellhausen S. R., Polk H. C., Jr HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg. 1991 Jun;161(6):639–645. doi: 10.1016/0002-9610(91)91247-g. [DOI] [PubMed] [Google Scholar]
  8. Cooke W. T., Prior P. Determining disease activity in inflammatory bowel disease. J Clin Gastroenterol. 1984 Feb;6(1):17–25. [PubMed] [Google Scholar]
  9. Dimitriu-Bona A., Burmester G. R., Waters S. J., Winchester R. J. Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. J Immunol. 1983 Jan;130(1):145–152. [PubMed] [Google Scholar]
  10. Eckhardt R., Heinisch M., Meyer zum Büschenfelde K. H. Cellular immune reactions against common antigen, small intestine, and colon antigen in patients with Crohn's disease, ulcerative colitis, and cirrhosis of the liver. Scand J Gastroenterol. 1976;11(1):49–54. [PubMed] [Google Scholar]
  11. Engleman E. G., Charron D. J., Benike C. J., Stewart G. J. Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells. J Exp Med. 1980 Aug 1;152(2 Pt 2):99s–113s. [PubMed] [Google Scholar]
  12. Ertel W., Meldrum D. R., Morrison M. H., Ayala A., Chaudry I. H. Immunoprotective effect of a calcium channel blocker on macrophage antigen presentation function, major histocompatability class II antigen expression, and interleukin-1 synthesis after hemorrhage. Surgery. 1990 Aug;108(2):154–160. [PubMed] [Google Scholar]
  13. Falchuk K. R., Isselbacher K. J. Circulating antibodies to bovine albumin in ulcerative colitis and Crohn's disease. Characterization of the antibody response. Gastroenterology. 1976 Jan;70(1):5–8. [PubMed] [Google Scholar]
  14. Harvey R. F., Bradshaw J. M. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514–514. doi: 10.1016/s0140-6736(80)92767-1. [DOI] [PubMed] [Google Scholar]
  15. Hershman M. J., Cheadle W. G., Kuftinec D., Polk H. C., Jr, George C. D. An outcome predictive score for sepsis and death following injury. Injury. 1988 Jul;19(4):263–266. doi: 10.1016/0020-1383(88)90042-3. [DOI] [PubMed] [Google Scholar]
  16. Hershman M. J., Cheadle W. G., Wellhausen S. R., Davidson P. F., Polk H. C., Jr Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg. 1990 Feb;77(2):204–207. doi: 10.1002/bjs.1800770225. [DOI] [PubMed] [Google Scholar]
  17. Ling P. D., Warren M. K., Vogel S. N. Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J Immunol. 1985 Sep;135(3):1857–1863. [PubMed] [Google Scholar]
  18. Matthews N., Mayberry J. F., Rhodes J., Neale L., Munro J., Wensinck F., Lawson G. H., Rowland A. C., Berkhoff G. A., Barthold S. W. Agglutinins to bacteria in Crohn's disease. Gut. 1980 May;21(5):376–380. doi: 10.1136/gut.21.5.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Meuret G., Bitzi A., Hammer B. Macrophage turnover in Crohn's disease and ulcerative colitis. Gastroenterology. 1978 Mar;74(3):501–503. [PubMed] [Google Scholar]
  20. Nagai H., Fisher R. I., Cossman J., Oppenheim J. J. Decreased expression of class II major histocompatibility antigens on monocytes from patients with Hodgkin's disease. J Leukoc Biol. 1986 Mar;39(3):313–321. doi: 10.1002/jlb.39.3.313. [DOI] [PubMed] [Google Scholar]
  21. Polk H. C., Jr, George C. D., Wellhausen S. R., Cost K., Davidson P. R., Regan M. P., Borzotta A. P. A systematic study of host defense processes in badly injured patients. Ann Surg. 1986 Sep;204(3):282–299. [PMC free article] [PubMed] [Google Scholar]
  22. Sano H., Compton L. J., Shiomi N., Steinberg A. D., Jackson R. A., Sasaki T. Low expression of human histocompatibility leukocyte antigen-DR is associated with hypermethylation of human histocompatibility leukocyte antigen-DR alpha gene regions in B cells from patients with systemic lupus erythematosus. J Clin Invest. 1985 Oct;76(4):1314–1322. doi: 10.1172/JCI112105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Scott H., Solheim B. G., Brandtzaeg P., Thorsby E. HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol. 1980;12(1):77–82. doi: 10.1111/j.1365-3083.1980.tb00043.x. [DOI] [PubMed] [Google Scholar]
  24. Shirakawa F., Yamashita U., Suzuki H. Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Immunol. 1985 Jun;134(6):3560–3562. [PubMed] [Google Scholar]
  25. Smith B. R., Ault K. A. Increase of surface Ia-like antigen expression on human monocytes independent of antigenic stimuli. J Immunol. 1981 Nov;127(5):2020–2027. [PubMed] [Google Scholar]
  26. Snyder D. S., Beller D. I., Unanue E. R. Prostaglandins modulate macrophage Ia expression. Nature. 1982 Sep 9;299(5879):163–165. doi: 10.1038/299163a0. [DOI] [PubMed] [Google Scholar]
  27. Snyder D. S., Unanue E. R. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol. 1982 Nov;129(5):1803–1805. [PubMed] [Google Scholar]
  28. Sztein M. B., Steeg P. S., Johnson H. M., Oppenheim J. J. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest. 1984 Feb;73(2):556–565. doi: 10.1172/JCI111243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tabaqchali S., O'Donoghue D. P., Bettelheim K. A. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut. 1978 Feb;19(2):108–113. doi: 10.1136/gut.19.2.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tanner A. R., Arthur M. J., Wright R. Macrophage activation, chronic inflammation and gastrointestinal disease. Gut. 1984 Jul;25(7):760–783. doi: 10.1136/gut.25.7.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Thomas D. W., Yamashita U., Shevach E. M. Nature of the antigenic complex recognized by T lymphocytes. IV. Inhibition of antigen-specific T cell proliferation by antibodies to stimulator macrophage Ia antigens. J Immunol. 1977 Jul;119(1):223–226. [PubMed] [Google Scholar]
  32. Thyberg J., Graf W., Klingenström P. Intestinal fine structure in Crohn's disease. Lysosomal inclusions in epithelial cells and macrophages. Virchows Arch A Pathol Anat Histol. 1981;391(2):141–152. doi: 10.1007/BF00437592. [DOI] [PubMed] [Google Scholar]
  33. Triglia T., Burns G. F., Werkmeister J. A. Rapid changes in surface antigen expression by blood monocytes cultured in suspension or adherent to plastic. Blood. 1985 Apr;65(4):921–928. [PubMed] [Google Scholar]
  34. Tweardy D. J., Schacter B. Z., Ellner J. J. Association of altered dynamics of monocyte surface expression of human leukocyte antigen DR with immunosuppression in tuberculosis. J Infect Dis. 1984 Jan;149(1):31–37. doi: 10.1093/infdis/149.1.31. [DOI] [PubMed] [Google Scholar]
  35. Unanue E. R. The regulation of lymphocyte functions by the macrophage. Immunol Rev. 1978;40:227–255. doi: 10.1111/j.1600-065x.1978.tb00408.x. [DOI] [PubMed] [Google Scholar]
  36. Yem A. W., Parmely M. J. Modulation of Ia-like antigen expression and antigen-presenting activity of human monocytes by endotoxin and zymosan A. J Immunol. 1981 Dec;127(6):2245–2251. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES